The immunosuppressant tocilizumab may be a promising option for myeloma patients with COVID-19, a case study from China suggests. Dr Changcheng Zheng, MD, of the University of Science and Technology of China and colleagues detailed the case of a 60-year-old man with multiple myeloma who was hospitalised with chest tightness and shortness of breath and ...
First case of COVID-19 in a patient with multiple myeloma
By Nicola Garrett
7 Apr 2020